Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dimi Hoppe"'
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
IntroductionReal time prescription monitoring tools have been implemented in Australia to address the growing concerns of drug misuse, drug-related mortality and morbidity. The objective of this pilot study is to investigate the barriers and facilita
Externí odkaz:
https://doaj.org/article/a34b527ad6a6422ea30ce6741aade410
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 12 (2021)
Background: Retrospective analyses of large databases of treated patients can provide useful links to the presence of drug misuse or rare and infrequent adverse effects, such as agranulocytosis, diabetic ketoacidosis or neuroleptic malignant syndrome
Externí odkaz:
https://doaj.org/article/bee0822b36d44acb870488b856db982a
Autor:
Leila Karimi, Dimi Hoppe, Christine Burdick, Melissa Buultjens, Tissa Wijeratne, Sheila G. Crewther
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Objective: The review presents a systematic analysis of literature investigating the association between migraine and suicidal behaviors.Introduction: Migraine is a common neurological disorder. The prevalence of migraines increases with age from ado
Externí odkaz:
https://doaj.org/article/cf596f56e58944cd8f4f2b10264cde6d
Publikováno v:
Australian Health Review. 47:208-216
Objective The aim of this study is to investigate how healthcare practitioners use real-time prescription monitoring tools in clinical practice. Methods An online survey was distributed to Australian prescribers and pharmacists who use a real-time pr
Publikováno v:
Drug and Alcohol Review. 41:803-817
Prescription drug monitoring programs are a harm minimisation intervention and clinical decision support tool that address the public health concern surrounding prescription drug misuse. Given the large number of studies published to date and the ong
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 12 (2021)
Therapeutic Advances in Drug Safety
Therapeutic Advances in Drug Safety
Background: Retrospective analyses of large databases of treated patients can provide useful links to the presence of drug misuse or rare and infrequent adverse effects, such as agranulocytosis, diabetic ketoacidosis or neuroleptic malignant syndrome